Overview

Active Implantable Devices Market is estimated to value over USD 31.8 billion by 2027 end with a CAGR of over 6.5% during the forecast period 2020 to 2027.

The increased necessity for safer, effective and faster devices is a major driving factor contributing to the growth of the market. Additionally, factors like increased number of patients diagnosed with cardiovascular diseases, rising occurrence of neurological diseases, soaring investments and financial assistance for developing advanced products and a wide range of neurostimulator applications are predicted to drive the market growth further. Furthermore, the rising geriatric population is another factor contributing to the active implantable devices market growth. However, reimbursement policies that are unfavourable to the general population shall hamper the growth of the market substantially.

Market Segmentation:

By Product

• Implantable Cardiac Pacemakers
• Implantable Cardioverter Defibrillators
o Transvenous Implantable Cardioverter Defibrillators
• Biventricular Implantable Cardioverter Defibrillators
• Dual-Chamber Implantable Cardioverter Defibrillators
• Single-Chamber Implantable Cardioverter Defibrillators
o Subcutaneous Implantable Cardioverter Defibrillators
• Ventricular Assist Devices
• Implantable Heart Monitors/Insertable Loop Recorders
• Implantable Hearing Devices
• Neurostimulators
o Spinal Cord Stimulators
o Deep Brain Stimulators
o Sacral Nerve Stimulators
o Vagus Nerve Stimulators
o Gastric Electrical Stimulators

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

The market is categorised into product and region. The product segment is classified into implantable cardiac pacemakers, cardioverter defibrillators, ventricular assist devices, implantable heart monitors/insertable loop recorders, implantable hearing devices and neurostimulators. The implantable cardioverter defibrillators are predicted to hold the largest active implantable devices market share, and this is due to the rising prevalence of cardiovascular diseases, advancements in the development of implantable devices and increased insistence for these devices in developed nation. For instance, as per the National Institute of Health, over 50% of the deaths related to cardiovascular disorders are caused by sudden cardiac arrests and over 75% of the deaths are caused due to ventricular tachyarrhythmias.

Regional Analysis:

The North America region is anticipated to lead the market owing to the rising ageing population, increase in the occurrence of appalling diseases, rise in the overall healthcare expenditure and initiation of multiple projects for improving the healthcare infrastructure. The Asia Pacific region, however, is anticipated to grow at a remarkable rate during the forecasted timeframe owing to the rising geriatric population and increased preference towards fast and oily foods leading to obesity. Additionally, increased financial assistance from public and private entities for developing an efficient healthcare infrastructure has propelled the market growth in the region.

Competitive Landscape:

The prominent market players included are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC, Cochlear Limited, MED-EL, Sonova Holding AG, William Demant Holding A/S, Nurotron Biotechnology Co. Ltd.

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key market trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the global active implantable devices market by product and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com